Jenny Herman Net Worth, Biography, and Insider Trading
Jenny  Herman net worth and biography

Jenny Herman Biography and Net Worth

SVP of Schrödinger

Jenny Herman, senior vice president, finance and corporate controller, leads the company’s finance, accounting and payroll teams. She joined Schrödinger in 2002 as the company’s only accountant, and has held positions of increasing responsibility. She assumed the role of controller in 2010, vice president of finance in 2019,  and was promoted to her current position in 2021. During her tenure, Jenny has played a significant role in Schrödinger’s private financings, initial public offering, and subsequent follow-on, which has raised over $750 million in gross proceeds collectively. Prior to joining Schrödinger, Jenny worked at NYK Logistics (North America) in corporate accounting. Jenny graduated from University of Montana School of Business where she received her B.S. in both Accounting and Financial Management, as well as her B.A. in Drama and Dance. She is a certified public accountant.

What is Jenny Herman's net worth?

The estimated net worth of Jenny Herman is at least $242,276.60 as of February 12th, 2024. Herman owns 11,761 shares of Schrödinger stock worth more than $242,277 as of March 26th. This net worth approximation does not reflect any other assets that Herman may own. Learn More about Jenny Herman's net worth.

How do I contact Jenny Herman?

The corporate mailing address for Herman and other Schrödinger executives is 120 WEST 45TH STREET 17TH FLOOR, NEW YORK NY, 10036. Schrödinger can also be reached via phone at 212-295-5800 and via email at christina.tartaglia@sternir.com. Learn More on Jenny Herman's contact information.

Has Jenny Herman been buying or selling shares of Schrödinger?

Jenny Herman has not been actively trading shares of Schrödinger within the last three months. Most recently, Jenny Herman sold 787 shares of the business's stock in a transaction on Monday, February 12th. The shares were sold at an average price of $28.29, for a transaction totalling $22,264.23. Following the completion of the sale, the senior vice president now directly owns 11,761 shares of the company's stock, valued at $332,718.69. Learn More on Jenny Herman's trading history.

Who are Schrödinger's active insiders?

Schrödinger's insider roster includes Robert Abel (Insider), Karen Akinsanya (Insider), Margaret Dugan (Insider), Jenny Herman (SVP), Rosana Kapeller-Libermann (Director), Joel Lebowitz (CFO), Kenneth Lorton (COO), Geoffrey Porges (CFO), David Shaw (Major Shareholder), Yvonne Tran (EVP), and Jorg Weiser (Director). Learn More on Schrödinger's active insiders.

Are insiders buying or selling shares of Schrödinger?

During the last twelve months, insiders at the sold shares 2 times. They sold a total of 7,022 shares worth more than $146,705.34. The most recent insider tranaction occured on March, 3rd when CFO Geoffrey Craig Porges sold 5,491 shares worth more than $119,484.16. Insiders at Schrödinger own 8.6% of the company. Learn More about insider trades at Schrödinger.

Information on this page was last updated on 3/3/2025.

Jenny Herman Insider Trading History at Schrödinger

See Full Table

Jenny Herman Buying and Selling Activity at Schrödinger

This chart shows Jenny Herman's buying and selling at Schrödinger by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$20k-$10k$0$10k$20kTotal Insider BuyingTotal Insider Selling

Schrödinger Company Overview

Schrödinger logo
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Read More

Today's Range

Now: $20.60
Low: $20.52
High: $21.51

50 Day Range

MA: $23.06
Low: $18.69
High: $26.15

2 Week Range

Now: $20.60
Low: $16.67
High: $29.15

Volume

650,916 shs

Average Volume

746,404 shs

Market Capitalization

$1.50 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.62